PPBT (Purple Biotech) Pangali Forward P/E
The growth of Purple Biotech (PPBT) is based on the successful trials of the CM24 drug and the patent protection of its formulas, which increases the likelihood of M&A. The company's estimated forward P/E on the GURU.Markets terminal chart clearly demonstrates the valuation dynamics, where 0.00 determines the current status of the parameter. However, geopolitical risks and threats to regional infrastructure limit the export of innovations, making business stability dependent on the results of clinical trials.
Ringkesan rincian data analitis Kitov Pharma (PPBT)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Purple Biotech|PPBT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Purple Biotech|PPBT - Gunggung tanggungan utang perusahaan|Utang marang nilai buku Purple Biotech Ltd|PPBT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Purple Biotech|Likuiditas cepet purple-biotech.com
- rincian asil keuangan lan kelipatan valuasi:
PPBT - Bathi sawise pajeg|Bathi sing dikarepake Purple Biotech|PPBT - Rasio rega marang bathi|Pangali Forward P/E Purple Biotech Corp|PPBT - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Purple Biotech Ltd|PPBT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Purple Biotech|PPBT - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan purple-biotech.com|PPBT - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Purple Biotech
Pambiji fundamental perusahaan:Purple Biotech Ltd. PPBT
Purple Biotech is currently in the pre-commercial stage of developing targeted antibodies, where business valuation is driven by clinical trial success rather than current revenue. By analyzing the company's expected P/E trend, an investor compares market capitalization with projected earnings, which helps identify asset overvaluation or hidden liquidity risks within the startup's capital structure.
Analisis perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Rega marang bathi mangsa ngarep Y-mAbs Therapeutics (YMAB)|AURA: Rasio rega marang bathi sing dikarepake|Candel Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali Forward P/E Accuray Inc ARAY|SLS - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi ACTU (Actuate Therapeutics Inc)|Citius Oncology, Inc. (CTOR) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake HURA (TuHURA Biosciences)|Rega marang bathi mangsa ngarep Protara Therapeutics, Inc.|Rega marang bathi mangsa ngarep FATE|Pangali Forward P/E WHWK|TCRX - Rasio prakiraan rega marang bathi|Champions Oncology, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi XBIT|CEL-SCI Corp - Pangali Forward P/E|OSTX: Rega marang bathi mangsa ngarep|RADX: Pangali Forward P/E|ARTV - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Adlai Nortye Ltd|Rasio prakiraan rega marang bathi verupharma.com VERU|Prakiraan rega marang bathi TPST (Tempest Therapeutics, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep XLO|Pangali Forward P/E RENB (Renovaro)|Mural Oncology PLC (MURA) - Rasio prakiraan rega marang bathi|Kairos Pharma Inc - Pangali Forward P/E|OnKure Therapeutics Inc (OKUR) - Prakiraan rega marang bathi|GDTC: Pangali Forward P/E|Curis - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Apollomics Inc.|Tharimmune Corporation - Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep Advanced Biomed Inc (ADVB)|GNPX: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E CLDI (Calidi Biotherapeutics, Inc.)|Sunshine Biopharma Inc. - Rega marang bathi mangsa ngarep|XBIO: Prakiraan rega marang bathi|Salarius Pharma - Rasio kapitalisasi marang bathi mangsa ngarep|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|CKPT (Checkpoint Therapeutics, Inc.) - Pangali Forward P/E|Pangali Forward P/E elevationoncology.com|Rega marang bathi mangsa ngarep iCAD, Inc. (ICAD)|ikenaoncology.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E NTBL (Notable Labs, Ltd.)|VIRX - Prakiraan rega marang bathi|MorphoSys - Pangali Forward P/E|Rasio prakiraan rega marang bathi NAYA Biosciences Inc|Ascentage Pharma Group Ltd (AAPGV) - Rega marang bathi mangsa ngarep
